南通本草八达医药科技香港

Nantong Bencao Bada Pharmaceutical Technology is a specialized contract research and development organization (CRO/CDMO) headquartered in Nantong, China, with a corporate presence in Hong Kong. The company was established by Bencao Capital to provide high-end medicinal chemistry and process development services to the global life sciences industry. Its core capabilities include the design and synthesis of focused chemical libraries, lead optimization, and the development of efficient synthetic routes for complex small molecules. Bencao Bada operates state-of-the-art laboratory facilities equipped for custom synthesis and pilot-scale production of key intermediates and active pharmaceutical ingredients. The firm serves as a strategic partner for both emerging biotech startups and established pharmaceutical companies, helping to accelerate the transition from drug discovery to clinical development. By integrating advanced chemical technologies with rigorous project management, the company delivers cost-effective and timely solutions for challenging synthetic problems.